Brief: Basilea Pharmaceutica Announces A Partnership With INCATE
Jan 13 (Reuters) - BASILEA PHARMACEUTICA AG ALLSCHWIL BSLN.S: ANNOUNCED TODAY A PARTNERSHIP WITH INCATE (INCUBATOR FOR ANTIBACTERIAL THERAPIES IN EUROPE), AN ANTIMICROBIAL INCUBATOR SUPPORTING ADVANCEMENT OF EARLY STAGE ANTI-INFECTIVES Source text: ID:nGNE2FLFMc Further company coverage: BSLN.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Basilea Pharmaceutica AG, Allschwil
See all newsBrief: Basilea Pharmaceutica - Strong Cresemba Sales In Europe Trigger USD 37.5 Mln Milestone Payment
Basilea seen up after raising 2026 guidance
Brief: Basilea Expects 2026 Operating Profit Of CHF 115 Mln
Brief: Basilea Reports Presentation Of New Data For Fosmanogepix, Isavuconazole And Ceftobiprole At IDWeek 2026
RCS - Accession Theraptcs. - Accession Therapeutics: Board appointments